M&T Bank’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.5M | Buy |
124,179
+17,298
| +16% | +$3.34M | 0.08% | 180 |
|
|
2025
Q4 | $19.7M | Sell |
106,881
-1,944
| -2% | -$341K | 0.06% | 206 |
|
|
2025
Q3 | $16.7M | Sell |
108,825
-638
| -0.6% | -$96.6K | 0.06% | 212 |
|
|
2025
Q2 | $15.3M | Sell |
109,463
-17,962
| -14% | -$2.52M | 0.05% | 232 |
|
|
2025
Q1 | $18.7M | Buy |
127,425
+5,836
| +5% | +$844K | 0.07% | 206 |
|
|
2024
Q4 | $15.9M | Sell |
121,589
-3,966
| -3% | -$555K | 0.05% | 220 |
|
|
2024
Q3 | $19.6M | Sell |
125,555
-8,360
| -6% | -$1.35M | 0.06% | 207 |
|
|
2024
Q2 | $20.9M | Buy |
133,915
+8,997
| +7% | +$1.35M | 0.07% | 197 |
|
|
2024
Q1 | $16.9M | Sell |
124,918
-13,137
| -10% | -$1.74M | 0.06% | 233 |
|
|
2023
Q4 | $18.6M | Sell |
138,055
-5,589
| -4% | -$727K | 0.07% | 220 |
|
|
2023
Q3 | $19.5M | Buy |
143,644
+2,387
| +2% | +$326K | 0.08% | 200 |
|
|
2023
Q2 | $20.2M | Sell |
141,257
-3,070
| -2% | -$452K | 0.08% | 217 |
|
|
2023
Q1 | $20M | Sell |
144,327
-4,213
| -3% | -$567K | 0.08% | 210 |
|
|
2022
Q4 | $20.1M | Buy |
148,540
+1,960
| +1% | +$246K | 0.08% | 213 |
|
|
2022
Q3 | $16.1M | Buy |
146,580
+46,469
| +46% | +$5.9M | 0.07% | 223 |
|
|
2022
Q2 | $12.8M | Buy |
100,111
+3,478
| +4% | +$456K | 0.06% | 229 |
|
|
2022
Q1 | $12.8M | Sell |
96,633
-5,967
| -6% | -$716K | 0.06% | 237 |
|
|
2021
Q4 | $12M | Sell |
102,600
-8,278
| -7% | -$974K | 0.05% | 243 |
|
|
2021
Q3 | $13.3M | Buy |
110,878
+10,389
| +10% | +$1.21M | 0.06% | 232 |
|
|
2021
Q2 | $12M | Sell |
100,489
-395
| -0.4% | -$43.3K | 0.05% | 246 |
|
|
2021
Q1 | $10M | Sell |
100,884
-11,342
| -10% | -$1.14M | 0.04% | 265 |
|
|
2020
Q4 | $11.2M | Sell |
112,226
-8,585
| -7% | -$909K | 0.05% | 243 |
|
|
2020
Q3 | $13.2M | Sell |
120,811
-5,473
| -4% | -$609K | 0.07% | 207 |
|
|
2020
Q2 | $13.4M | Sell |
126,284
-6,491
| -5% | -$670K | 0.07% | 201 |
|
|
2020
Q1 | $11.9M | Buy |
132,775
+9,323
| +8% | +$878K | 0.07% | 215 |
|
|
2019
Q4 | $12.3M | Sell |
123,452
-1,772
| -1% | -$167K | 0.06% | 179 |
|
|
2019
Q3 | $11.2M | Sell |
125,224
-2,623
| -2% | -$227K | 0.06% | 231 |
|
|
2019
Q2 | $10.6M | Sell |
127,847
-363
| -0.3% | -$28.5K | 0.06% | 239 |
|
|
2019
Q1 | $10.4M | Sell |
128,210
-12,162
| -9% | -$959K | 0.05% | 235 |
|
|
2018
Q4 | $10.7M | Sell |
140,372
-9,507
| -6% | -$742K | 0.06% | 217 |
|
|
2018
Q3 | $11.9M | Buy |
149,879
+336
| +0.2% | +$25.4K | 0.06% | 228 |
|
|
2018
Q2 | $10.5M | Sell |
149,543
-3,612
| -2% | -$260K | 0.06% | 242 |
|
|
2018
Q1 | $10.7M | Sell |
153,155
-5,405
| -3% | -$374K | 0.06% | 245 |
|
|
2017
Q4 | $11M | Buy |
158,560
+838
| +0.5% | +$56.5K | 0.06% | 244 |
|
|
2017
Q3 | $10.7M | Sell |
157,722
-1,564
| -1% | -$98.8K | 0.06% | 237 |
|
|
2017
Q2 | $10.9M | Sell |
159,286
-24
| -0% | -$1.57K | 0.06% | 230 |
|
|
2017
Q1 | $9.92M | Buy |
159,310
+5,650
| +4% | +$329K | 0.06% | 232 |
|
|
2016
Q4 | $8.4M | Sell |
153,660
-375,888
| -71% | -$21.3M | 0.05% | 243 |
|
|
2016
Q3 | $34.8M | Buy |
529,548
+13,769
| +3% | +$900K | 0.22% | 106 |
|
|
2016
Q2 | $31.1M | Buy |
515,779
+79,482
| +18% | +$4.62M | 0.21% | 112 |
|
|
2016
Q1 | $24.6M | Buy |
436,297
+49,609
| +13% | +$2.98M | 0.17% | 136 |
|
|
2015
Q4 | $26.3M | Buy |
386,688
+22,443
| +6% | +$1.47M | 0.17% | 129 |
|
|
2015
Q3 | $23.2M | Buy |
364,245
+264,316
| +265% | +$17.4M | 0.16% | 136 |
|
|
2015
Q2 | $6.37M | Buy |
99,929
+8,400
| +9% | +$575K | 0.04% | 301 |
|
|
2015
Q1 | $6.26M | Buy |
91,529
+87
| +0.1% | +$6.04K | 0.04% | 322 |
|
|
2014
Q4 | $6.44M | Buy |
91,442
+4,655
| +5% | +$333K | 0.04% | 319 |
|
|
2014
Q3 | $6.2M | Buy |
86,787
+82,943
| +2,158% | +$6.07M | 0.04% | 319 |
|
|
2014
Q2 | $286K | Sell |
3,844
-1,449
| -27% | -$105K | 0.01% | 462 |
|
|
2014
Q1 | $344K | Sell |
5,293
-389
| -7% | -$25.1K | 0.01% | 434 |
|
|
2013
Q4 | $337K | Sell |
5,682
-151
| -3% | -$8.2K | 0.01% | 427 |
|
|
2013
Q3 | $303K | Buy |
5,833
+126
| +2% | +$6.33K | 0.01% | 369 |
|
|
2013
Q2 | $270K | Buy |
+5,707
| New | +$291K | 0.01% | 373 |
|
Other funds holding AZN
IA
VCM
VAM
M&T Bank's AZN Position: Q1 2026 in Review
M&T Bank increased its AstraZeneca (AZN) stake by 16% in Q1 2026, buying an estimated $3.34M and bringing the position to 124,179 shares worth $24.5M. The position accounts for 0.08% of the portfolio, ranked #180.
M&T Bank first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. The position peaked at $34.8M in Q3 2016. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- M&T Bank held 124,179 shares of AstraZeneca worth $24.5M as of Q1 2026.
- M&T Bank bought 17,298 AstraZeneca shares in Q1 2026, an estimated $3.34M.
- AstraZeneca made up 0.08% of M&T Bank's portfolio in Q1 2026, its #180 holding.
- M&T Bank first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
- M&T Bank's AstraZeneca position peaked at $34.8M in Q3 2016.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.